Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2013-03-27

Clinical Trial Update: Efficacy of Alogliptin With Pioglitazone (Actos®) in Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy of combining alogliptin with pioglitazone (Actos) in adults with Type 2 diabetes mellitus; results were posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Actos (Pioglitazone)
  • Nesina (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus | Phase 3 | Status: COMPLETED | Results posted: 2013-03-27